These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 17636013

  • 1. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J, Rajput AB, Lu H, Sanguin-Gendreau V, Zuo D, Papavasiliou V, Lavoie C, Turpin J, Cianflone K, Huntsman DG, Muller WJ.
    Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents.
    Brandt R, Wong AM, Hynes NE.
    Oncogene; 2001 Sep 06; 20(39):5459-65. PubMed ID: 11571643
    [Abstract] [Full Text] [Related]

  • 4. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A, Rosner A, Milovanovic T, Hope C, Planutis K, Saha B, Chaiwun B, Lin F, Imam SA, Marsh JL, Holcombe RF.
    Int J Oncol; 2005 Oct 06; 27(4):949-56. PubMed ID: 16142310
    [Abstract] [Full Text] [Related]

  • 5. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS, Sun W, Nomata K, Morita I, Cruz A, Liu CJ, Trosko JE, Chang CC.
    Mol Carcinog; 1998 Apr 06; 21(4):225-33. PubMed ID: 9585252
    [Abstract] [Full Text] [Related]

  • 6. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD.
    Mol Cancer Res; 2009 Nov 06; 7(11):1882-92. PubMed ID: 19861407
    [Abstract] [Full Text] [Related]

  • 7. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H, Chen WD, Qin X, Lee K, Liu L, Markowitz SD, Gerson SL.
    Oncogene; 2001 Sep 20; 20(42):6009-17. PubMed ID: 11593408
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T, Luoh SW.
    Carcinogenesis; 2008 Mar 20; 29(3):473-9. PubMed ID: 17916906
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
    Shyamala G, Chou YC, Cardiff RD, Vargis E.
    Cancer Res; 2006 Nov 01; 66(21):10391-8. PubMed ID: 17079459
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
    Landis MD, Seachrist DD, Abdul-Karim FW, Keri RA.
    Oncogene; 2006 Jun 01; 25(23):3325-34. PubMed ID: 16434967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
    Zhang H, Kuang SQ, Liao L, Zhou S, Xu J.
    Cancer Res; 2004 Oct 01; 64(19):7169-77. PubMed ID: 15466215
    [Abstract] [Full Text] [Related]

  • 19. CdGAP is required for transforming growth factor β- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    He Y, Northey JJ, Primeau M, Machado RD, Trembath R, Siegel PM, Lamarche-Vane N.
    Oncogene; 2011 Mar 03; 30(9):1032-45. PubMed ID: 21042277
    [Abstract] [Full Text] [Related]

  • 20. Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.
    Croci S, Nicoletti G, Landuzzi L, Palladini A, Chiarini F, Nanni P, Lollini PL, De Giovanni C.
    Oncol Rep; 2007 Aug 03; 18(2):451-6. PubMed ID: 17611670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.